Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riitta Lassila

Showing results (41-50 of 162) with videos related to

Pageof 17
Sort By:
Clinical Chemistry|February 5, 2013
Laboratory assessment of novel oral anticoagulants: method suitability and variability between coagulation laboratoriesTuukka A Helin, Anja Pakkanen, Riitta Lassila, et al.
Research and Practice in Thrombosis and Haemostasis|April 19, 2021
Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated ThrombogramTuukka A Helin, Marja Lemponen, Riitta Lassila, et al.
Cancer Medicine|May 21, 2026
Preoperative Biomarker Panel With Fibrinogen, FVIII, and CA 19-9 as a Tool for Prognostic Evaluation in Neoadjuvant-Treated Pancreatic Ductal AdenocarcinomaNora Mattila, Riitta Lassila, Harri Mustonen, et al.
Journal of Cardiothoracic and Vascular Anesthesia|February 10, 2007
Heparin-induced thrombocytopenia following cardiac surgery is associated with poor outcomeAnne Kuitunen, Raili Suojaranta-Ylinen, Peter Raivio, et al.
European Heart Journal|March 25, 2004
Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventionsAino Lepäntalo, Kari S Virtanen, Juhani Heikkilä, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 9, 2023
Upregulation of Coagulation Factor VIII and Fibrinogen After Pulmonary Endarterectomy in Patients with Chronic Thromboembolic Pulmonary HypertensionLasse Myllylahti, Jussi Ropponen, Mikko Lax, et al.
BMJ Open|November 2, 2023
Associations of anaemia with bleeding and thrombotic complications in patients with atrial fibrillation treated with warfarin: a registry-based nested case-control studyTuukka Antero Helin, Pekka Raatikainen, Mika Lehto, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|November 12, 2019
Novel Locally Acting Dual Antiplatelet and Anticoagulant (APAC) Targets Multiple Sites of Vascular Injury in an Experimental Porcine ModelKarina A Barreiro, Riikka Tulamo, Annukka Jouppila, et al.
Blood Vessels, Thrombosis & Hemostasis|April 20, 2026
Interactions of dual antiplatelet and anticoagulant with C1q and FH regulate complement activation by injured cellsJuha Kotimaa, Mikel Artero Rezola, Annukka Jouppila, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 8, 2022
Switching from standard to extended half-life FVIII prophylaxis in haemophilia A: Comparison of factor product use, bleed rates and pharmacokineticsVuokko Nummi, Anna-Elina Lehtinen, Alfonso Iorio, et al.
Pageof 17

Showing results (41-50 of 162) with videos related to

Sort By:
Pageof 17
Clinical Chemistry|February 5, 2013
Laboratory assessment of novel oral anticoagulants: method suitability and variability between coagulation laboratoriesTuukka A Helin, Anja Pakkanen, Riitta Lassila, et al.
Research and Practice in Thrombosis and Haemostasis|April 19, 2021
Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated ThrombogramTuukka A Helin, Marja Lemponen, Riitta Lassila, et al.
Cancer Medicine|May 21, 2026
Preoperative Biomarker Panel With Fibrinogen, FVIII, and CA 19-9 as a Tool for Prognostic Evaluation in Neoadjuvant-Treated Pancreatic Ductal AdenocarcinomaNora Mattila, Riitta Lassila, Harri Mustonen, et al.
Journal of Cardiothoracic and Vascular Anesthesia|February 10, 2007
Heparin-induced thrombocytopenia following cardiac surgery is associated with poor outcomeAnne Kuitunen, Raili Suojaranta-Ylinen, Peter Raivio, et al.
European Heart Journal|March 25, 2004
Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventionsAino Lepäntalo, Kari S Virtanen, Juhani Heikkilä, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 9, 2023
Upregulation of Coagulation Factor VIII and Fibrinogen After Pulmonary Endarterectomy in Patients with Chronic Thromboembolic Pulmonary HypertensionLasse Myllylahti, Jussi Ropponen, Mikko Lax, et al.
BMJ Open|November 2, 2023
Associations of anaemia with bleeding and thrombotic complications in patients with atrial fibrillation treated with warfarin: a registry-based nested case-control studyTuukka Antero Helin, Pekka Raatikainen, Mika Lehto, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|November 12, 2019
Novel Locally Acting Dual Antiplatelet and Anticoagulant (APAC) Targets Multiple Sites of Vascular Injury in an Experimental Porcine ModelKarina A Barreiro, Riikka Tulamo, Annukka Jouppila, et al.
Blood Vessels, Thrombosis & Hemostasis|April 20, 2026
Interactions of dual antiplatelet and anticoagulant with C1q and FH regulate complement activation by injured cellsJuha Kotimaa, Mikel Artero Rezola, Annukka Jouppila, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 8, 2022
Switching from standard to extended half-life FVIII prophylaxis in haemophilia A: Comparison of factor product use, bleed rates and pharmacokineticsVuokko Nummi, Anna-Elina Lehtinen, Alfonso Iorio, et al.
Pageof 17